Ketamine in acute phase of severe traumatic brain injury “an old drug for new uses?”

Compartilhe ►

Crit Care

  • 2021 Jan 6;25(1):19. doi: 10.1186/s13054-020-03452-x.

Ketamine in acute phase of severe traumatic brain injury “an old drug for new uses?”

Daniel Agustin Godoy 1 2Rafael Badenes 3 4 5Paolo Pelosi 6 7Chiara Robba 8 9Affiliations expand

Free PMC article

Abstract

Maintaining an adequate level of sedation and analgesia plays a key role in the management of traumatic brain injury (TBI). To date, it is unclear which drug or combination of drugs is most effective in achieving these goals. Ketamine is an agent with attractive pharmacological and pharmacokinetics characteristics. Current evidence shows that ketamine does not increase and may instead decrease intracranial pressure, and its safety profile makes it a reliable tool in the prehospital environment. In this point of view, we discuss different aspects of the use of ketamine in the acute phase of TBI, with its potential benefits and pitfalls.

Keywords: Agitation; Cooperative sedation; Ketamine; Neuroprotection; Secondary insult; Sedation; Traumatic brain injury.

Conflict of interest statement

No conflict of interest.

Similar articles

See all similar articles

Cited by 1 article

References

  1. Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7:728–741. doi: 10.1016/S1474-4422(08)70164-9. – DOI – PubMed

Editor do blog: Julio Pereira – Neurocirugião – São Paulo CRM/SP 163.113 Site para Consulta: https://www.julio-pereira.com/ Consultório: (11)99503-8838 (WhatsApp) / (11)4200-2300 Atuando no Hospital Sírio-Libanês e na BP – A Beneficência Portuguesa de São Paulo.

CONFIRA NOSSOS SITES:
Cirurgia de Coluna
Tumor Cerebral
Aneurisma Cerebral
Radiocirurgia
Neuro Cancer
WeNeuro